BioCentury
ARTICLE | Financial News

Xenogen postpones IPO

February 20, 2001 8:00 AM UTC

Xenogen (Alameda, Calif.), a developer of in vivo biphotonic imaging technology, postponed its 7 million-share IPO, citing market conditions. The company originally filed to raise up to $86.3 million ...